Search research articles
Contact Us
Filters
Showing results (101-110 of 261) with videos related to
Page
of 27
Sort By:
BMC Medical Informatics and Decision Making
|
February 9, 2022
Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
Mieke Van Hemelrijck, Eugenio Ventimiglia, David Robinson, et al.
BMC Cancer
|
November 28, 2018
Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
Arunangshu Ghoshal, Hans Garmo, Niklas Hammar, et al.
Journal of Cancer Epidemiology
|
September 13, 2012
Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
Wahyu Wulaningsih, Hans Garmo, Lars Holmberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 10, 2025
Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer
Pietro Scilipoti, Ola Bratt, Hans Garmo, et al.
Atherosclerosis
|
June 13, 2016
Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study
Sabine Rohrmann, Hans Garmo, Håkan Malmström, et al.
Urology
|
July 22, 2008
PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer
David Robinson, Gabriel Sandblom, Robert Johansson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2013
Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins
Karl Michaëlsson, Peter Nordström, Anna Nordström, et al.
BJU International
|
October 27, 2015
Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy
Sean O'Farrell, Karin Sandström, Hans Garmo, et al.
BMC Cancer
|
June 17, 2020
Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
E Lin, Hans Garmo, Mieke Van Hemelrijck, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 18, 2023
Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
Tiago M Bonde, Hans Garmo, Pär Stattin, et al.
Page
of 27
Search research articles
Search
Showing results (101-110 of 261) with videos related to
Sort By:
Page
of 27
BMC Medical Informatics and Decision Making
|
February 9, 2022
Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
Mieke Van Hemelrijck, Eugenio Ventimiglia, David Robinson, et al.
BMC Cancer
|
November 28, 2018
Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
Arunangshu Ghoshal, Hans Garmo, Niklas Hammar, et al.
Journal of Cancer Epidemiology
|
September 13, 2012
Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
Wahyu Wulaningsih, Hans Garmo, Lars Holmberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 10, 2025
Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer
Pietro Scilipoti, Ola Bratt, Hans Garmo, et al.
Atherosclerosis
|
June 13, 2016
Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study
Sabine Rohrmann, Hans Garmo, Håkan Malmström, et al.
Urology
|
July 22, 2008
PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer
David Robinson, Gabriel Sandblom, Robert Johansson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2013
Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins
Karl Michaëlsson, Peter Nordström, Anna Nordström, et al.
BJU International
|
October 27, 2015
Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy
Sean O'Farrell, Karin Sandström, Hans Garmo, et al.
BMC Cancer
|
June 17, 2020
Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
E Lin, Hans Garmo, Mieke Van Hemelrijck, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 18, 2023
Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
Tiago M Bonde, Hans Garmo, Pär Stattin, et al.
Page
of 27